Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B608090-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
B608090-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,001.90 |
Synonyms | Bimosiamose [INN] | (Hexane-1,6-diylbis(6'-(alpha-D-mannopyranosyloxy)biphenyl-3',3-diyl))diacetic acid | UNII-97B5KCW80W | SCHEMBL12182030 | 97B5KCW80W | BDBM50324667 | 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydro |
---|---|
Specifications & Purity | Moligand™ |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Selectin inhibitor |
ALogP | 4.2 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetic acid |
---|---|
INCHI | InChI=1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1 |
InChi Key | RYWCQJDEHXJHRI-XJMXIVSISA-N |
Canonical SMILES | OC[C@H]1O[C@H](Oc2ccc(cc2c2cccc(c2)CC(=O)O)CCCCCCc2ccc(c(c2)c2cccc(c2)CC(=O)O)O[C@H]2O[C@H](CO)[C@H]([C@@H]([C@@H]2O)O)O)[C@H]([C@H]([C@@H]1O)O)O |
Isomeric SMILES | C1=CC(=CC(=C1)C2=C(C=CC(=C2)CCCCCCC3=CC(=C(C=C3)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C5=CC=CC(=C5)CC(=O)O)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)CC(=O)O |
PubChem CID | 9811353 |
Molecular Weight | 862.9 |
PubChem CID | 9811353 |
---|---|
ChEMBL Ligand | CHEMBL1215923 |
CAS Registry No. | 187269-40-5 |
BindingDB Ligand | 50324667 |
Enter Lot Number to search for COA:
1. Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, Issekutz A, Kasiske BL, Keane WF, Rabb H. (2001) Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure.. Kidney Int, 60 (6): (2205-14). [PMID:11737594] |
2. Romano SJ, Slee DH. (2001) Targeting selectins for the treatment of respiratory diseases.. Curr Opin Investig Drugs, 2 (7): (907-13). [PMID:11757789] |
3. Onai Y, Suzuki J, Nishiwaki Y, Gotoh R, Berens K, Dixon R, Yoshida M, Ito H, Isobe M. (2003) Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury.. Eur J Pharmacol, 481 (2-3): (217-25). [PMID:14642789] |
4. Vanderslice P, Biediger RJ, Woodside DG, Berens KL, Holland GW, Dixon RA. (2004) Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD.. Pulm Pharmacol Ther, 17 (1): (1-10). [PMID:14643165] |
5. Hicks AE, Abbitt KB, Dodd P, Ridger VC, Hellewell PG, Norman KE. (2005) The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo.. J Leukoc Biol, 77 (1): (59-66). [PMID:15466915] |
6. Toledo-Pereyra LH, Lopez-Neblina F, Reuben JS, Toledo AH, Ward PA. (2004) Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion.. J Invest Surg, 17 (6): (303-13). [PMID:15764497] |
7. Anaya-Prado R, Pérez-Gomez N, Toledo-Pereyra LH, Walsh J, Jordan J, Ward PA. (2008) Small molecule selectin inhibitor in global cerebral ischemia and controlled hemorrhagic shock.. J Trauma, 65 (3): (678-84). [PMID:18784584] |
8. Calvey CR, Toledo-Pereyra LH. (2007) Selectin inhibitors and their proposed role in ischemia and reperfusion.. J Invest Surg, 20 (2): (71-85). [PMID:17454392] |
9. Watz H, Bock D, Meyer M, Schierhorn K, Vollhardt K, Woischwill C, Pedersen F, Kirsten A, Beeh KM, Meyer-Sabellek W et al.. (2013) Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.. Pulm Pharmacol Ther, 26 (2): (265-70). [PMID:23257347] |
10. Kogan TP, Dupré B, Bui H, McAbee KL, Kassir JM, Scott IL, Hu X, Vanderslice P, Beck PJ, Dixon RA. (1998) Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).. J Med Chem, 41 (7): (1099-111). [PMID:9544210] |